{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:19:04Z","timestamp":1776770344741,"version":"3.51.2"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1093\/jac\/dkq495","type":"journal-article","created":{"date-parts":[[2010,12,25]],"date-time":"2010-12-25T01:35:08Z","timestamp":1293240908000},"page":"578-587","source":"Crossref","is-referenced-by-count":39,"title":["Chemical modification of capuramycins to enhance antibacterial activity"],"prefix":"10.1093","volume":"66","author":[{"given":"Elena","family":"Bogatcheva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tia","family":"Dubuisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Protopopova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo","family":"Einck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol A.","family":"Nacy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata M.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,12,23]]},"reference":[{"key":"key\n\t\t\t\t20170425171828_DKQ495C1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/187152606784112128","article-title":"Phospho-MurNAc-pentapeptide translocase (MraY) as a target for antibacterial agents and antibacterial proteins","volume":"6","author":"Bugg","year":"2006","journal-title":"Infect Disord Drug Targets"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1039\/b202149h","article-title":"Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesis","volume":"20","author":"Kimura","year":"2003","journal-title":"Nat Prod Rep"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.7164\/antibiotics.56.253","article-title":"Studies on novel bacterial\u00a0 translocase I inhibitors, A-500359s. II Biological activities of A-500359 A, C, D and G","volume":"56","author":"Muramatsu","year":"2003","journal-title":"J Antibiot"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C4","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.7164\/antibiotics.39.1047","article-title":"Capuramycin, a new nucleoside antibiotic. Taxonomy, fermentation, isolation and characterization","volume":"39","author":"Yamaguchi","year":"1986","journal-title":"J Antibiot"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.7164\/antibiotics.56.243","article-title":"Studies on novel bacterial translocase I inhibitors, A-500359s. I Taxonomy, fermentation, isolation, physico-chemical properties and structure elucidation of A-500359 A, C, D and G","volume":"56","author":"Muramatsu","year":"2003","journal-title":"J Antibiot"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C6","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1016\/S0960-894X(03)00596-1","article-title":"Synthesis and antimycobacterial activity of capuramycin\u00a0 analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin","volume":"13","author":"Hotoda","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C7","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1016\/S0960-894X(03)00597-3","article-title":"Synthesis and antimycobacterial activity of capuramycin analogues. Part 2: acylated derivatives of capuramycin-related compounds","volume":"13","author":"Hotoda","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C8","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0960-894X(00)00349-8","article-title":"Synthesis of the nucleoside moiety of liposidomycins: elucidation of the pharmacophore of this family of MraY inhibitors","volume":"10","author":"Dini","year":"2000","journal-title":"Bioorg Med Chem Lett"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C9","article-title":"Antibacterial compound","author":"Hotoda","year":"2007"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/jac\/dkh417","article-title":"Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo","volume":"54","author":"Koga","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C11","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1128\/AAC.01469-07","article-title":"In vitro antimycobacterial activities of capuramycin analogues","volume":"52","author":"Reddy","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C12","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1128\/AAC.00366-09","article-title":"Activity of SQ641, a capuramycin analogue, in a murine model of tuberculosis","volume":"53","author":"Nikonenko","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C13","article-title":"Enhancement of intracellular activity of capuramycin (CM) analogue SQ641 against M. tuberculosis (H37Rv)","author":"Reddy"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C14","doi-asserted-by":"crossref","first-page":"12899","DOI":"10.1074\/jbc.M110.104141","article-title":"Functional and kinetic analysis of the phosphotrasferase CapP conferring selective self-resistance to capuramycin antibiotics","volume":"285","author":"Yang","year":"2010","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ja.2009.38","article-title":"Identification of the biosynthetic gene cluster of A-500359s in Streptomyces griseus SANK60196","volume":"62","author":"Funabashi","year":"2009","journal-title":"J Antibiot"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/117739280700200003","article-title":"Targeting receptors, transporters and site of absorption to improve oral drug delivery","volume":"2","author":"Hamman","year":"2007","journal-title":"Drug Target Insight"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/psc.1129","article-title":"Peptide conjugates of therapeutically used antitubercular isoniazid-design, synthesis and\u00a0 antimycobacterial effect","volume":"15","author":"Horvati","year":"2009","journal-title":"J Pept Sci"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C18","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/B0-08-045044-X\/00157-7","article-title":"Prodrug objective and design","volume-title":"Comprehensive Medicinal Chemistry II","author":"Testa","year":"2007"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2897","article-title":"Subcellular targeting strategies for drug design and delivery","volume":"9","author":"Rajendran","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C20","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1128\/IAI.67.9.4586-4593.1999","article-title":"Assessment of immunity to mycobacterial infection with luciferase reporter constructs","volume":"67","author":"Snewin","year":"1999","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C21","first-page":"89","article-title":"Drug susceptibility tests in the management of chemotherapy of\u00a0 tuberculosis","volume-title":"Drug Susceptibility in the Chemotherapy of Mycobacterial Infections","author":"Heifets","year":"1998"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C22","first-page":"1108","article-title":"Susceptibility test methods: dilution and disk diffusion methods","volume-title":"Manual of Clinical Microbiology","author":"Jorgensen","year":"2003","edition":"8th edn"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C23","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1128\/JCM.24.6.976-981.1986","article-title":"Susceptibility testing of slow growing\u00a0 mycobacteria by a microdilution MIC method with 7H9 broth","volume":"24","author":"Wallace","year":"1986","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C24","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1128\/AAC.01601-09","article-title":"In vitro interactions between new antitubercular drug candidates SQ109 and TMC207","volume":"54","author":"Reddy","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.biochem.78.082907.145923","article-title":"Multidrug resistance in bacteria","volume":"78","author":"Nikaido","year":"2009","journal-title":"Annu Rev Biochem"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C26","first-page":"1074","article-title":"Mechanisms of resistance to antimicrobial agents","volume-title":"Manual of Clinical Microbiology","author":"Rice","year":"2003","edition":"8th edn"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/jac\/dki171","article-title":"Efflux-mediated antimicrobial resistance","volume":"56","author":"Poole","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C28","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.19.2.382-402.2006","article-title":"Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria","volume":"19","author":"Piddock","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1042\/bj20020957","article-title":"Structure and function of efflux pumps that confer resistance to drugs","volume":"376","author":"Borges-Walmsley","year":"2003","journal-title":"Biochem J"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1574-6976.2005.00002.x","article-title":"Role of mycobacterial efflux transporters in drug\u00a0 resistance: an unresolved question","volume":"30","author":"Rossi","year":"2005","journal-title":"FEMS Microbiol Rev"},{"key":"key\n\t\t\t\t20170425171828_DKQ495C31","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1365-2958.2006.05584.x","article-title":"How do antibiotic-producing bacteria ensure their self-resistance before antibiotic biosynthesis incapacitates them?","volume":"63","author":"Hopwood","year":"2007","journal-title":"Mol Microbiol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/66\/3\/578\/13762227\/dkq495.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:24:02Z","timestamp":1592180642000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkq495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,23]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2010,12,23]]},"published-print":{"date-parts":[[2011,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkq495","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,23]]}}}